LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
MILLIONS TUNED IN FROM ACROSS THE WORLD TO SEE THE LEGENDARY ARTIST’S UNFORGETTABLE PERFORMANCE AHEAD OF THE BIGGEST GAME IN CLUB FOOTBALL Watch the UEFA Champions League final Kick Off Show by Pepsi performance HERE LONDON, June 2, 2024 /PRNewswire/ — #PepsiKickOffShow Rock icon Lenny K
Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
PORT MORESBY, Papua New Guinea, June 2, 2024 /PRNewswire/ — A team from Pacific Wrecks discovered one of the most famous World War II aircraft in Papua New Guinea. Two weeks later, Papua New Guinea officials signed a Letter of Intent with Poplar, Wisconsin to become Sister Cities. The twin ann
Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
Results of survey will be presented by Adrian Dobs, M.D., Professor of Medicine and Oncology, The Johns Hopkins School of Medicine, and Sandeep Dhindsa, M.B.B.S., Director of Division of Endocrinology, Diabetes and Metabolism, St. Louis University School of Medicine, at ENDO 2024 in Boston on Jun
Message from the Governor General on Canadian Environment Week
OTTAWA, ON, June 2, 2024 /CNW/ – Canadian Environment Week is a reminder that we need to take action to protect and preserve our planet for future generations. Across Canada and around the world, we are seeing the impacts of climate change. There has been an increase in extreme weather events
Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
LAGOS, Nigeria, June 2, 2024 /PRNewswire/ — The Federal Government through the Nigeria Data Protection Commission (NDPC) has granted a licence to the Institute of Information Management (IIM) to conduct examinations and certify data protection professionals for global competitiveness. The Nati
MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
The PRIMED study found a way to reduce treatment-related side effects among participants, decreasing dose reductions, treatment interruptions, and permanent discontinuations.The strategic alliance between MEDSIR and Oncoclínicas has enabled the company to present 13 studies at the 2024 ASCO Annual
Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
-Trial-in-Progress poster provides overview on PEMDA-HN trial evaluating danvatirsen in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with recurrent/metastatic HNSCC- LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, June 2, 2024 /PRNewswire/ R
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
TAIPEI, June 2, 2024 /PRNewswire/ — ASRock Rack Inc., a leading innovative server company, has launched several scale-up servers leveraging the NVIDIA Blackwell architecture at the ASRock Rack booth L0818 in Hall 1 of COMPUTEX 2024. The highlights of the launch are the ORV3 NVIDIA GB200 NVL72,
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
TAIPEI, June 2, 2024 /PRNewswire/ — ASRock Rack Inc., a leading innovative server company, has launched several scale-up servers leveraging the NVIDIA Blackwell architecture at the ASRock Rack booth L0818 in Hall 1 of COMPUTEX 2024. The highlights of the launch are the ORV3 NVIDIA GB200 NVL72,
Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
-Trial-in-Progress poster provides overview on PEMDA-HN trial evaluating danvatirsen in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with recurrent/metastatic HNSCC- LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, June 2, 2024 /PRNewswire/ R
